Popa; Igor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Popa; Igor.The latest application filed is for "substituted 6-(alkylbenzylamino) purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives".

Company Profile

0.6.6

Popa; Igor - Olomouc N/A CZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic compounds based on N.sup.6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds Grant 8,552,013 - Popa , et al. October 8, 2	2013-10-08
Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives Grant 8,492,391 - Zatloukal , et al. July 23, 2	2013-07-23
Substituted 6-(alkylbenzylamino) Purine Derivatives For Use As Cytokinin Receptor Antagonists And Preparations Containing These Derivatives App 20130130906 - SPICHAL; LUKAS ; et al.	2013-05-23
Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives App 20120070512 - Zatloukal; Marek ; et al.	2012-03-22
Substitution derivatives of N.sup.6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds Grant 8,119,614 - Dolezal , et al. February 21, 2	2012-02-21
Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives App 20100240537 - Spichal; Lukas ; et al.	2010-09-23
Heterocyclic Compounds Based On N6-substituted Adenine, Methods Of Their Preparation, Their Use For Preparation Of Drugs, Cosmetic Preparations And Growth Regulators, Pharmaceutical Preparations, Cosmetic Preparations And Growth Regulators Containing These Compounds App 20080014227 - Popa; Igor ; et al.	2008-01-17
Heterocyclic compound based on N.sup.6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds Grant 7,279,482 - Dolezal , et al. October 9, 2	2007-10-09
Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds App 20060166925 - Dolezal; Karel ; et al.	2006-07-27
Heterocyclic compound based on n6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds App 20050043328 - Dolezal, Karel ; et al.	2005-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.